Plesa, A., COELHO, A., Mathis, S., Saada, V., Arnoux, I., Bardet, V., Dumezy, F., Chauvel, C., Zhu, J., Nivaggioni, V., Manzoni, D., Oster, I., Penther, D., Duployez, N., Celli-Lebras, K., Raus, N., Raffoux, E., Adès, L., Willekens, C., Micol, J., Botton, S. D., Farnault, L., Chantepie, S., Cluzeau, T., HIEULLE, J., Berthon, C., Aljijakli, A., Bories, C., Wattebled, K., Buffet, R., Itzykson, R., Dombret, H., Preudhomme, C., Roumier, C. (2025). Real-life CD34+CD38- leukemic stem cell (LSC) flow quantification in adult AML at diagnosis independently predicts survival of intensively but not AZA-VEN treated patients: A study of prospective observational ALFA-PPP acute leukemia french association. Blood. https://doi.org/10.1182/blood-2025-3483